➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Patent: 10,017,492

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,017,492

Title:	Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
Abstract:	Provided are an isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof. The isoindoline derivative and the pharmaceutical composition thereof can regulate the production or activity of immunological cytokines, thus effectively treating cancer and inflammatory disease. ##STR00001##
Inventor(s):	Ge; Chuansheng (Shanghai, CN), Lee; Wen-Cherng (Shanghai, CN), Liao; Baisong (Shanghai, CN), Zhang; Lei (Shanghai, CN)
Assignee:	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)
Application Number:	15/523,651
Patent Claims:	see list of patent claims

Details for Patent 10,017,492

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech Inc	HERCEPTIN HYLECTA	trastuzumab; hyaluronidase-oysk	INJECTABLE;SUBCUTANEOUS	761106	001	2019-02-28	⤷ Try it Free	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX		search
Genentech Inc	RITUXAN HYCELA	rituximab; hyaluronidase (human recombinant)	SOLUTION;SUBCUTANEOUS	761064	002	2017-06-22	⤷ Try it Free	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX	Orphan	search
Genentech Inc	RITUXAN HYCELA	rituximab; hyaluronidase (human recombinant)	SOLUTION;SUBCUTANEOUS	761064	001	2017-06-22	⤷ Try it Free	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	002	2015-11-30	⤷ Try it Free	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	⤷ Try it Free	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,017,492

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016065980	⤷ Try it Free
United States of America	2017313676	⤷ Try it Free
Russian Federation	2017118453	⤷ Try it Free
Russian Federation	2695521	⤷ Try it Free
Portugal	3214081	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

AstraZeneca

Express Scripts

Boehringer Ingelheim

Harvard Business School

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.